Nestlé to advance bioeffective ingredients for precision nutrition through planned R&D expansion
The deep tech center is scheduled to open in the first half of 2026 within the Nestlé System Technology Center in Orbe, Switzerland.
SWITZERLAND – Nestlé has announced the strengthening of its R&D expertise in biotechnology and the creation of a new center for deep tech, meant to boost its innovation pipeline and increase efficiency in research, innovation and operations.
The deep tech center is scheduled to open in the first half of 2026 within the Nestlé System Technology Center in Orbe, Switzerland.
Its goal is to deliver new ingredients with clinically proven bio-efficacy for precision nutrition, targeting people and pets along their entire lifespan.
The investments will be unlocked by a leaner research and development (R&D) organization, more agile ways of working, a focused project portfolio and the redeployment of existing R&D resources.
“We continue to transform our R&D organization to embrace science and technology trends and to seize current and future growth opportunities. The industry-leading biotechnology capabilities will deliver new ingredients with clinically proven bio-efficacy for precision nutrition for people and pets along their entire lifespan,” Stefan Palzer, CTO of Nestlé S.A., said.
By building on existing expertise in sensor systems, solutions for product recognition, remote control and display solutions, the new center will screen, test and develop new generations of sensors, robots, coding systems, high-performing AI and virtual/mixed reality solutions. This will increase efficiency in research, innovation and operations.
New technologies will enable the development of smart coffee machines, innovative solutions for precision nutrition, self-controlling equipment and new solutions for dynamic quality assurance.
The enhanced R&D expertise in cutting-edge biotechnology and clinical research, leading to new nutritional solutions, will further bolster Nestlé’s consumer-centric innovation pipelines.
This will cut across maternal, early life and medical nutrition, while supporting new growth platforms such as healthy longevity, women’s health and weight management.
Science-based solutions will also be leveraged for Nestlé’s pet care business, including pet therapeutics.
New capabilities include the development of the next generation of screening assays, enhanced capabilities in precision fermentation, as well as a re-enforced clinical research program.
These competences will drive significant advances in precision nutrition and the development of new generations of highly effective bio-actives and biotics including post- and synbiotics.
“These new capabilities in bio tech and deep tech will fuel growth by meeting changing consumer needs and accelerating the digital transformation of Nestlé. This is about putting the Nestlé Virtuous Circle in action: unlocking investment through efficiencies to drive more focused and impactful innovation and growth,” Laurent Freixe, CEO of Nestlé S.A., commented.
This new deep tech center is intended to be a first-of-its-kind in the food and nutrition industry.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
